

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exocrine pancreas development (GO:0031017) | 8.07759693 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 7.40236461 |
| 3 | protein retention in ER lumen (GO:0006621) | 6.54091258 |
| 4 | digestion (GO:0007586) | 6.30069791 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.14484239 |
| 6 | signal peptide processing (GO:0006465) | 5.33943341 |
| 7 | regulation of phospholipase A2 activity (GO:0032429) | 4.94565475 |
| 8 | CENP-A containing nucleosome assembly (GO:0034080) | 4.82074094 |
| 9 | chromatin remodeling at centromere (GO:0031055) | 4.75076060 |
| 10 | positive regulation of heat generation (GO:0031652) | 4.44974834 |
| 11 | regulation of fever generation (GO:0031620) | 4.37806574 |
| 12 | proteasome assembly (GO:0043248) | 4.35220031 |
| 13 | transcytosis (GO:0045056) | 4.33192996 |
| 14 | glycolipid catabolic process (GO:0019377) | 4.31224922 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.18194843 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.17347746 |
| 17 | membrane lipid catabolic process (GO:0046466) | 4.16656161 |
| 18 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.12743936 |
| 19 | ceramide catabolic process (GO:0046514) | 4.08431571 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07787002 |
| 21 | mitotic metaphase plate congression (GO:0007080) | 4.07578448 |
| 22 | protein localization to kinetochore (GO:0034501) | 4.05754582 |
| 23 | DNA strand elongation (GO:0022616) | 4.02279764 |
| 24 | mitotic sister chromatid segregation (GO:0000070) | 4.02106842 |
| 25 | establishment of integrated proviral latency (GO:0075713) | 4.01635574 |
| 26 | cobalamin metabolic process (GO:0009235) | 3.86344005 |
| 27 | L-serine metabolic process (GO:0006563) | 3.85834431 |
| 28 | cullin deneddylation (GO:0010388) | 3.84645258 |
| 29 | histone exchange (GO:0043486) | 3.84625980 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.80145519 |
| 31 | sister chromatid segregation (GO:0000819) | 3.79358607 |
| 32 | regulation of heat generation (GO:0031650) | 3.76921041 |
| 33 | kinetochore organization (GO:0051383) | 3.75559564 |
| 34 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.75090212 |
| 35 | DNA replication-independent nucleosome organization (GO:0034724) | 3.72748447 |
| 36 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.72748447 |
| 37 | mitochondrial calcium ion transport (GO:0006851) | 3.70337757 |
| 38 | metaphase plate congression (GO:0051310) | 3.69428027 |
| 39 | protein deneddylation (GO:0000338) | 3.65205390 |
| 40 | mitotic recombination (GO:0006312) | 3.60355382 |
| 41 | protein localization to chromosome, centromeric region (GO:0071459) | 3.58913346 |
| 42 | telomere maintenance via recombination (GO:0000722) | 3.53045415 |
| 43 | DNA ligation (GO:0006266) | 3.52542368 |
| 44 | DNA replication checkpoint (GO:0000076) | 3.50604100 |
| 45 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.45245151 |
| 46 | kinetochore assembly (GO:0051382) | 3.43059006 |
| 47 | cholesterol catabolic process (GO:0006707) | 3.39778758 |
| 48 | sterol catabolic process (GO:0016127) | 3.39778758 |
| 49 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.39541192 |
| 50 | mitotic chromosome condensation (GO:0007076) | 3.38600201 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.38266565 |
| 52 | establishment of viral latency (GO:0019043) | 3.33570846 |
| 53 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.28274307 |
| 54 | glyoxylate metabolic process (GO:0046487) | 3.22513808 |
| 55 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.22365105 |
| 56 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.22135759 |
| 57 | leukotriene biosynthetic process (GO:0019370) | 3.22111976 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.20888864 |
| 59 | regulation of mitochondrial translation (GO:0070129) | 3.15171777 |
| 60 | DNA unwinding involved in DNA replication (GO:0006268) | 3.14507542 |
| 61 | intestinal absorption (GO:0050892) | 3.12651430 |
| 62 | serine family amino acid biosynthetic process (GO:0009070) | 3.12568828 |
| 63 | response to peptidoglycan (GO:0032494) | 3.11539860 |
| 64 | leukotriene metabolic process (GO:0006691) | 3.10441670 |
| 65 | establishment of chromosome localization (GO:0051303) | 3.09445095 |
| 66 | negative regulation of ligase activity (GO:0051352) | 3.09302211 |
| 67 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.09302211 |
| 68 | spindle checkpoint (GO:0031577) | 3.07538120 |
| 69 | sphingolipid catabolic process (GO:0030149) | 3.02026055 |
| 70 | myeloid leukocyte mediated immunity (GO:0002444) | 3.00277729 |
| 71 | branched-chain amino acid catabolic process (GO:0009083) | 3.00060921 |
| 72 | purine nucleobase biosynthetic process (GO:0009113) | 2.99421308 |
| 73 | glycine metabolic process (GO:0006544) | 2.99126553 |
| 74 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.96970797 |
| 75 | chaperone-mediated protein transport (GO:0072321) | 2.92162239 |
| 76 | regulation of chromosome segregation (GO:0051983) | 2.91747862 |
| 77 | amyloid precursor protein catabolic process (GO:0042987) | 2.91340164 |
| 78 | telomere maintenance via telomere lengthening (GO:0010833) | 2.91274190 |
| 79 | peptidyl-proline hydroxylation (GO:0019511) | 2.91057599 |
| 80 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.89187577 |
| 81 | mitotic spindle checkpoint (GO:0071174) | 2.89177160 |
| 82 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.87257885 |
| 83 | response to interferon-beta (GO:0035456) | 2.84975012 |
| 84 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.84893874 |
| 85 | negative regulation of digestive system process (GO:0060457) | 2.83377438 |
| 86 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.81357955 |
| 87 | negative regulation of sister chromatid segregation (GO:0033046) | 2.81357955 |
| 88 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.81357955 |
| 89 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.81357955 |
| 90 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.81357955 |
| 91 | DNA replication initiation (GO:0006270) | 2.81128411 |
| 92 | negative regulation of chromosome segregation (GO:0051985) | 2.80876887 |
| 93 | protein K6-linked ubiquitination (GO:0085020) | 2.80771709 |
| 94 | regulation of chemokine secretion (GO:0090196) | 2.80751482 |
| 95 | chromosome segregation (GO:0007059) | 2.80452014 |
| 96 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.80159274 |
| 97 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.80159274 |
| 98 | regulation of centriole replication (GO:0046599) | 2.79690776 |
| 99 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.79461058 |
| 100 | DNA double-strand break processing (GO:0000729) | 2.79150615 |
| 101 | neutrophil activation (GO:0042119) | 2.78936871 |
| 102 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.78467842 |
| 103 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.78405434 |
| 104 | cellular response to interferon-beta (GO:0035458) | 2.78346030 |
| 105 | DNA damage response, detection of DNA damage (GO:0042769) | 2.77126771 |
| 106 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.76561951 |
| 107 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.75542259 |
| 108 | non-recombinational repair (GO:0000726) | 2.75542259 |
| 109 | desmosome organization (GO:0002934) | 2.75500119 |
| 110 | mitotic spindle assembly checkpoint (GO:0007094) | 2.75332586 |
| 111 | spindle assembly checkpoint (GO:0071173) | 2.74370633 |
| 112 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.74069524 |
| 113 | Golgi transport vesicle coating (GO:0048200) | 2.73962840 |
| 114 | COPI coating of Golgi vesicle (GO:0048205) | 2.73962840 |
| 115 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.72780978 |
| 116 | granulocyte activation (GO:0036230) | 2.72697996 |
| 117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.71803081 |
| 118 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.71803081 |
| 119 | cell cycle G1/S phase transition (GO:0044843) | 2.69348134 |
| 120 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.69348134 |
| 121 | protein maturation by protein folding (GO:0022417) | 2.67919011 |
| 122 | valine metabolic process (GO:0006573) | 2.67516267 |
| 123 | GDP-mannose metabolic process (GO:0019673) | 2.66969836 |
| 124 | aldehyde catabolic process (GO:0046185) | 2.66903918 |
| 125 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.66014682 |
| 126 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.66014682 |
| 127 | resolution of meiotic recombination intermediates (GO:0000712) | 2.65463991 |
| 128 | ventricular cardiac muscle cell development (GO:0055015) | 2.64705824 |
| 129 | replication fork processing (GO:0031297) | 2.64046932 |
| 130 | sphingoid metabolic process (GO:0046519) | 2.63397857 |
| 131 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.62919032 |
| 132 | branched-chain amino acid metabolic process (GO:0009081) | 2.62211473 |
| 133 | detection of other organism (GO:0098543) | 2.61950561 |
| 134 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.61854045 |
| 135 | DNA topological change (GO:0006265) | 2.60801320 |
| 136 | serine family amino acid metabolic process (GO:0009069) | 2.60798382 |
| 137 | positive regulation of ligase activity (GO:0051351) | 2.60457235 |
| 138 | regulation of spindle organization (GO:0090224) | 2.59745154 |
| 139 | regulation of mitotic spindle organization (GO:0060236) | 2.59176713 |
| 140 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.59102148 |
| 141 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.59102148 |
| 142 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.59102148 |
| 143 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.58205504 |
| 144 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.57456283 |
| 145 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.57362037 |
| 146 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.57362037 |
| 147 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.57348998 |
| 148 | protein localization to chromosome (GO:0034502) | 2.57077088 |
| 149 | positive regulation of chemokine secretion (GO:0090197) | 2.56874978 |
| 150 | positive regulation of interferon-alpha production (GO:0032727) | 2.56650194 |
| 151 | mitotic cell cycle (GO:0000278) | 2.56487942 |
| 152 | ribosome assembly (GO:0042255) | 2.55989226 |
| 153 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.55786123 |
| 154 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.52931456 |
| 155 | respiratory burst (GO:0045730) | 2.52062659 |
| 156 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51102663 |
| 157 | positive regulation by symbiont of host defense response (GO:0052509) | 2.49692700 |
| 158 | modulation by symbiont of host defense response (GO:0052031) | 2.49692700 |
| 159 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.49692700 |
| 160 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.49692700 |
| 161 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.49692700 |
| 162 | modulation by symbiont of host immune response (GO:0052553) | 2.49692700 |
| 163 | leukocyte aggregation (GO:0070486) | 2.48615789 |
| 164 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48243783 |
| 165 | proline biosynthetic process (GO:0006561) | 2.48234895 |
| 166 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47226121 |
| 167 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.44492969 |
| 168 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.44238133 |
| 169 | cellular response to type I interferon (GO:0071357) | 2.43437561 |
| 170 | type I interferon signaling pathway (GO:0060337) | 2.43437561 |
| 171 | peptide catabolic process (GO:0043171) | 2.42991394 |
| 172 | response to type I interferon (GO:0034340) | 2.41957497 |
| 173 | regulation of interferon-alpha production (GO:0032647) | 2.40541628 |
| 174 | superoxide anion generation (GO:0042554) | 2.40358641 |
| 175 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.38838721 |
| 176 | cysteine metabolic process (GO:0006534) | 2.38098198 |
| 177 | regulation of activation of Janus kinase activity (GO:0010533) | 2.36310686 |
| 178 | cellular response to exogenous dsRNA (GO:0071360) | 2.35748555 |
| 179 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.34646937 |
| 180 | glucosamine-containing compound catabolic process (GO:1901072) | 2.33848212 |
| 181 | antibacterial humoral response (GO:0019731) | 2.32727858 |
| 182 | sphingosine metabolic process (GO:0006670) | 2.32724143 |
| 183 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.31202687 |
| 184 | antimicrobial humoral response (GO:0019730) | 2.29203551 |
| 185 | T-helper 1 type immune response (GO:0042088) | 2.28130716 |
| 186 | reactive oxygen species biosynthetic process (GO:1903409) | 2.27049200 |
| 187 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.26857590 |
| 188 | positive regulation of acute inflammatory response (GO:0002675) | 2.26489120 |
| 189 | regulation of antigen processing and presentation (GO:0002577) | 2.26287256 |
| 190 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.25663326 |
| 191 | I-kappaB phosphorylation (GO:0007252) | 2.25057944 |
| 192 | regulation of hypersensitivity (GO:0002883) | 2.23311383 |
| 193 | response to endoplasmic reticulum stress (GO:0034976) | 2.22956720 |
| 194 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.22857458 |
| 195 | regulation of chemokine biosynthetic process (GO:0045073) | 2.22743694 |
| 196 | positive regulation of T cell migration (GO:2000406) | 2.22029202 |
| 197 | intestinal epithelial cell development (GO:0060576) | 2.21553148 |
| 198 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.19199984 |
| 199 | immunoglobulin mediated immune response (GO:0016064) | 2.19108402 |
| 200 | regulation of interleukin-8 secretion (GO:2000482) | 2.18434706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.00418379 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.27647848 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.07172737 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.66197053 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.41050583 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.20311416 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.07366201 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.55813126 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.54364789 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.44525621 |
| 11 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 3.32774870 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.21805178 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.20825211 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.19263605 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.14388780 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.01027946 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95415334 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91748080 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.81323796 |
| 20 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.74132916 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72152792 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.68171818 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.65731386 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.60083993 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.55718623 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.49160016 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47240621 |
| 28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.45324344 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.43621350 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.42710479 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.42304139 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.40521163 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34282256 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31841219 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.26717081 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.25738997 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22729724 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22440449 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22251095 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.22204908 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.14629637 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10616822 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.10407412 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.07670293 |
| 45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06121917 |
| 46 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.06118392 |
| 47 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.01023585 |
| 48 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.98768058 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97340333 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95424053 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94693144 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90507918 |
| 53 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.89641943 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.88828674 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.81582987 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79998668 |
| 57 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.79415474 |
| 58 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.78660095 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.76855238 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75057895 |
| 61 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.74550973 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.73678911 |
| 63 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.73484914 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72196462 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71180681 |
| 66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.70897917 |
| 67 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.68811947 |
| 68 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.65693484 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.63768340 |
| 70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.63502972 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.61065465 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59306052 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57382139 |
| 74 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56903076 |
| 75 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56796212 |
| 76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56400377 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55977131 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55605686 |
| 79 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.51449984 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49674013 |
| 81 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.48465315 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46345394 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.45660663 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44662338 |
| 85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42632130 |
| 86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41644593 |
| 87 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41066706 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40122477 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39972611 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39972611 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37766935 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37191584 |
| 93 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36914086 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34302044 |
| 95 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32021549 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31802104 |
| 97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31460468 |
| 98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29765857 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29728319 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.29609034 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29034437 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27942186 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.27910276 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26982937 |
| 105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25055851 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24782164 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24688563 |
| 108 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.24623355 |
| 109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.24051185 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23367986 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19771613 |
| 112 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19302385 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19043195 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18803732 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18803732 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18443146 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 1.17983483 |
| 118 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17590825 |
| 119 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17590825 |
| 120 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17590825 |
| 121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16322196 |
| 122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15494700 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15201456 |
| 124 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.14056024 |
| 125 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13681349 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13595481 |
| 127 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13400161 |
| 128 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13335361 |
| 129 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.10921228 |
| 130 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10470835 |
| 131 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10122246 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09321233 |
| 133 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.08899791 |
| 134 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07757245 |
| 135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05019297 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04726347 |
| 137 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03266602 |
| 138 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02188812 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01958463 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.01426150 |
| 141 | FUS_26573619_Chip-Seq_HEK293_Human | 1.00947008 |
| 142 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99906219 |
| 143 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99319236 |
| 144 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98173440 |
| 145 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98132670 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97625968 |
| 147 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97155244 |
| 148 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96913405 |
| 149 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.96152723 |
| 150 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95315775 |
| 151 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94858605 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94204670 |
| 153 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93881517 |
| 154 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93647861 |
| 155 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93329510 |
| 156 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92981961 |
| 157 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91920240 |
| 158 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91258553 |
| 159 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91083040 |
| 160 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90469988 |
| 161 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90172667 |
| 162 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88754312 |
| 163 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88749866 |
| 164 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88615667 |
| 165 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88334405 |
| 166 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88184772 |
| 167 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87745454 |
| 168 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87582569 |
| 169 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87423544 |
| 170 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87392537 |
| 171 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85929625 |
| 172 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83112764 |
| 173 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82854683 |
| 174 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82424230 |
| 175 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80789101 |
| 176 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80467663 |
| 177 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80308837 |
| 178 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.79940249 |
| 179 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79481598 |
| 180 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.79057935 |
| 181 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.78929813 |
| 182 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.78418263 |
| 183 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.77626834 |
| 184 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.76441593 |
| 185 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75846949 |
| 186 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75512047 |
| 187 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.73071250 |
| 188 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.72246200 |
| 189 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.69361578 |
| 190 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.68945779 |
| 191 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.68444675 |
| 192 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.65946870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 5.14179007 |
| 2 | MP0005083_abnormal_biliary_tract | 4.97999120 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.81852617 |
| 4 | MP0005220_abnormal_exocrine_pancreas | 3.63046585 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.41494028 |
| 6 | MP0009697_abnormal_copulation | 3.34285735 |
| 7 | MP0005365_abnormal_bile_salt | 3.24195171 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 3.00268002 |
| 9 | MP0008058_abnormal_DNA_repair | 3.00130383 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.97145917 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.80892929 |
| 12 | MP0003077_abnormal_cell_cycle | 2.72657568 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.69689596 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.60282965 |
| 15 | MP0005084_abnormal_gallbladder_morpholo | 2.57574564 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.55018479 |
| 17 | MP0009785_altered_susceptibility_to | 2.52572979 |
| 18 | MP0003436_decreased_susceptibility_to | 2.42926830 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.40474006 |
| 20 | MP0006082_CNS_inflammation | 2.38407638 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.33905752 |
| 22 | MP0002938_white_spotting | 2.31539968 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.26952308 |
| 24 | MP0003724_increased_susceptibility_to | 2.22800120 |
| 25 | MP0006292_abnormal_olfactory_placode | 2.15551886 |
| 26 | MP0000372_irregular_coat_pigmentation | 2.15243960 |
| 27 | MP0003718_maternal_effect | 2.14421044 |
| 28 | MP0003868_abnormal_feces_composition | 2.05002571 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 2.04452765 |
| 30 | MP0008007_abnormal_cellular_replicative | 2.01112836 |
| 31 | MP0001293_anophthalmia | 1.99558556 |
| 32 | MP0002796_impaired_skin_barrier | 1.97806521 |
| 33 | MP0002419_abnormal_innate_immunity | 1.95264440 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.93101723 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.93077542 |
| 36 | MP0005171_absent_coat_pigmentation | 1.84516780 |
| 37 | MP0005025_abnormal_response_to | 1.82088134 |
| 38 | MP0001529_abnormal_vocalization | 1.78004567 |
| 39 | MP0002693_abnormal_pancreas_physiology | 1.72500848 |
| 40 | MP0004947_skin_inflammation | 1.69742404 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.67746700 |
| 42 | MP0003186_abnormal_redox_activity | 1.66700437 |
| 43 | MP0002009_preneoplasia | 1.65189129 |
| 44 | MP0008789_abnormal_olfactory_epithelium | 1.62211116 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.58990044 |
| 46 | MP0008004_abnormal_stomach_pH | 1.58555898 |
| 47 | MP0005671_abnormal_response_to | 1.57798454 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.57482911 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.55059252 |
| 50 | MP0002006_tumorigenesis | 1.54609143 |
| 51 | MP0000685_abnormal_immune_system | 1.54258895 |
| 52 | MP0005360_urolithiasis | 1.54252847 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.52973741 |
| 54 | MP0001873_stomach_inflammation | 1.51269537 |
| 55 | MP0003937_abnormal_limbs/digits/tail_de | 1.50695366 |
| 56 | MP0003941_abnormal_skin_development | 1.50043439 |
| 57 | MP0003890_abnormal_embryonic-extraembry | 1.49726543 |
| 58 | MP0005387_immune_system_phenotype | 1.48255716 |
| 59 | MP0001790_abnormal_immune_system | 1.48255716 |
| 60 | MP0002723_abnormal_immune_serum | 1.43033963 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 1.42094151 |
| 62 | MP0002452_abnormal_antigen_presenting | 1.41547270 |
| 63 | MP0002060_abnormal_skin_morphology | 1.41313623 |
| 64 | MP0002254_reproductive_system_inflammat | 1.40988600 |
| 65 | MP0005275_abnormal_skin_tensile | 1.40128759 |
| 66 | MP0002234_abnormal_pharynx_morphology | 1.37917937 |
| 67 | MP0005451_abnormal_body_composition | 1.37183494 |
| 68 | MP0009764_decreased_sensitivity_to | 1.36172777 |
| 69 | MP0002233_abnormal_nose_morphology | 1.35758696 |
| 70 | MP0006054_spinal_hemorrhage | 1.34254977 |
| 71 | MP0003959_abnormal_lean_body | 1.32910807 |
| 72 | MP0001664_abnormal_digestion | 1.31724059 |
| 73 | MP0005394_taste/olfaction_phenotype | 1.31573615 |
| 74 | MP0005499_abnormal_olfactory_system | 1.31573615 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.30956622 |
| 76 | MP0002697_abnormal_eye_size | 1.29924501 |
| 77 | MP0004381_abnormal_hair_follicle | 1.28156548 |
| 78 | MP0001800_abnormal_humoral_immune | 1.26626425 |
| 79 | MP0008469_abnormal_protein_level | 1.26553568 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.25813773 |
| 81 | MP0000358_abnormal_cell_content/ | 1.25773345 |
| 82 | MP0001819_abnormal_immune_cell | 1.23980550 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 1.22050878 |
| 84 | MP0002405_respiratory_system_inflammati | 1.21972252 |
| 85 | MP0002102_abnormal_ear_morphology | 1.21676060 |
| 86 | MP0003121_genomic_imprinting | 1.21069137 |
| 87 | MP0001216_abnormal_epidermal_layer | 1.20822847 |
| 88 | MP0003786_premature_aging | 1.20822715 |
| 89 | MP0008057_abnormal_DNA_replication | 1.20542921 |
| 90 | MP0002166_altered_tumor_susceptibility | 1.19345970 |
| 91 | MP0003638_abnormal_response/metabolism_ | 1.19283497 |
| 92 | MP0001697_abnormal_embryo_size | 1.18635445 |
| 93 | MP0000858_altered_metastatic_potential | 1.18266193 |
| 94 | MP0005187_abnormal_penis_morphology | 1.17971886 |
| 95 | MP0002282_abnormal_trachea_morphology | 1.16575619 |
| 96 | MP0001853_heart_inflammation | 1.16180238 |
| 97 | MP0005248_abnormal_Harderian_gland | 1.15976108 |
| 98 | MP0005464_abnormal_platelet_physiology | 1.15300324 |
| 99 | MP0009053_abnormal_anal_canal | 1.15065344 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 1.14351440 |
| 101 | MP0001730_embryonic_growth_arrest | 1.13874571 |
| 102 | MP0005165_increased_susceptibility_to | 1.13189542 |
| 103 | MP0001764_abnormal_homeostasis | 1.13065958 |
| 104 | MP0000350_abnormal_cell_proliferation | 1.09353554 |
| 105 | MP0001851_eye_inflammation | 1.09163109 |
| 106 | MP0002090_abnormal_vision | 1.08848384 |
| 107 | MP0003122_maternal_imprinting | 1.08091192 |
| 108 | MP0001286_abnormal_eye_development | 1.07963276 |
| 109 | MP0003123_paternal_imprinting | 1.07912987 |
| 110 | MP0000490_abnormal_crypts_of | 1.07317943 |
| 111 | MP0002092_abnormal_eye_morphology | 1.06542740 |
| 112 | MP0002085_abnormal_embryonic_tissue | 1.05768885 |
| 113 | MP0003755_abnormal_palate_morphology | 1.05700295 |
| 114 | MP0000566_synostosis | 1.04998814 |
| 115 | MP0005501_abnormal_skin_physiology | 1.04895519 |
| 116 | MP0003315_abnormal_perineum_morphology | 1.03881540 |
| 117 | MP0005408_hypopigmentation | 1.03834814 |
| 118 | MP0005380_embryogenesis_phenotype | 1.03590144 |
| 119 | MP0001672_abnormal_embryogenesis/_devel | 1.03590144 |
| 120 | MP0002998_abnormal_bone_remodeling | 1.02979064 |
| 121 | MP0005310_abnormal_salivary_gland | 1.02976288 |
| 122 | MP0004272_abnormal_basement_membrane | 1.02803033 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 1.01205940 |
| 124 | MP0002084_abnormal_developmental_patter | 1.00943310 |
| 125 | MP0003191_abnormal_cellular_cholesterol | 1.00743237 |
| 126 | MP0005257_abnormal_intraocular_pressure | 1.00446891 |
| 127 | MP0010678_abnormal_skin_adnexa | 1.00322205 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.98676522 |
| 129 | MP0005623_abnormal_meninges_morphology | 0.98412094 |
| 130 | MP0003195_calcinosis | 0.98154628 |
| 131 | MP0001663_abnormal_digestive_system | 0.97585041 |
| 132 | MP0000383_abnormal_hair_follicle | 0.96488909 |
| 133 | MP0003448_altered_tumor_morphology | 0.95868100 |
| 134 | MP0009379_abnormal_foot_pigmentation | 0.95081829 |
| 135 | MP0003303_peritoneal_inflammation | 0.94614901 |
| 136 | MP0000647_abnormal_sebaceous_gland | 0.94466287 |
| 137 | MP0002210_abnormal_sex_determination | 0.94352887 |
| 138 | MP0003705_abnormal_hypodermis_morpholog | 0.94326427 |
| 139 | MP0003075_altered_response_to | 0.93832298 |
| 140 | MP0006036_abnormal_mitochondrial_physio | 0.93080554 |
| 141 | MP0000377_abnormal_hair_follicle | 0.93028691 |
| 142 | MP0003183_abnormal_peptide_metabolism | 0.92990369 |
| 143 | MP0000049_abnormal_middle_ear | 0.92682070 |
| 144 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92310766 |
| 145 | MP0001929_abnormal_gametogenesis | 0.92265106 |
| 146 | MP0002080_prenatal_lethality | 0.92091987 |
| 147 | MP0002138_abnormal_hepatobiliary_system | 0.91788366 |
| 148 | MP0009384_cardiac_valve_regurgitation | 0.91678013 |
| 149 | MP0003385_abnormal_body_wall | 0.91267664 |
| 150 | MP0009643_abnormal_urine_homeostasis | 0.91008697 |
| 151 | MP0001324_abnormal_eye_pigmentation | 0.90741180 |
| 152 | MP0004147_increased_porphyrin_level | 0.90463787 |
| 153 | MP0003795_abnormal_bone_structure | 0.89260324 |
| 154 | MP0010368_abnormal_lymphatic_system | 0.88932544 |
| 155 | MP0004264_abnormal_extraembryonic_tissu | 0.88348785 |
| 156 | MP0005390_skeleton_phenotype | 0.87756576 |
| 157 | MP0002933_joint_inflammation | 0.86711062 |
| 158 | MP0002736_abnormal_nociception_after | 0.85579043 |
| 159 | MP0005395_other_phenotype | 0.84448976 |
| 160 | MP0003690_abnormal_glial_cell | 0.83506498 |
| 161 | MP0005197_abnormal_uvea_morphology | 0.83369231 |
| 162 | MP0003252_abnormal_bile_duct | 0.83100045 |
| 163 | MP0003172_abnormal_lysosome_physiology | 0.82944693 |
| 164 | MP0009333_abnormal_splenocyte_physiolog | 0.82858031 |
| 165 | MP0002111_abnormal_tail_morphology | 0.82341022 |
| 166 | MP0003119_abnormal_digestive_system | 0.81649461 |
| 167 | MP0000537_abnormal_urethra_morphology | 0.81430664 |
| 168 | MP0003136_yellow_coat_color | 0.80830044 |
| 169 | MP0000470_abnormal_stomach_morphology | 0.80788496 |
| 170 | MP0000343_altered_response_to | 0.80726056 |
| 171 | MP0010771_integument_phenotype | 0.80549284 |
| 172 | MP0006072_abnormal_retinal_apoptosis | 0.80284940 |
| 173 | MP0005391_vision/eye_phenotype | 0.79900944 |
| 174 | MP0000653_abnormal_sex_gland | 0.79725043 |
| 175 | MP0003984_embryonic_growth_retardation | 0.78930402 |
| 176 | MP0002877_abnormal_melanocyte_morpholog | 0.78911234 |
| 177 | MP0002118_abnormal_lipid_homeostasis | 0.78517167 |
| 178 | MP0001944_abnormal_pancreas_morphology | 0.77298468 |
| 179 | MP0000762_abnormal_tongue_morphology | 0.77178732 |
| 180 | MP0009672_abnormal_birth_weight | 0.76173346 |
| 181 | MP0001145_abnormal_male_reproductive | 0.75542491 |
| 182 | MP0005166_decreased_susceptibility_to | 0.75454708 |
| 183 | MP0003763_abnormal_thymus_physiology | 0.75162592 |
| 184 | MP0002088_abnormal_embryonic_growth/wei | 0.74625147 |
| 185 | MP0003950_abnormal_plasma_membrane | 0.73174798 |
| 186 | MP0002160_abnormal_reproductive_system | 0.72994241 |
| 187 | MP0002095_abnormal_skin_pigmentation | 0.69038417 |
| 188 | MP0000778_abnormal_nervous_system | 0.68604680 |
| 189 | MP0002751_abnormal_autonomic_nervous | 0.68377696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.11199195 |
| 2 | Steatorrhea (HP:0002570) | 4.62007820 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.21880311 |
| 4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.09684074 |
| 5 | Increased serum pyruvate (HP:0003542) | 4.06650979 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.06602338 |
| 7 | Abnormality of glycolysis (HP:0004366) | 4.03253154 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.91638124 |
| 9 | Chromsome breakage (HP:0040012) | 3.83076006 |
| 10 | Fat malabsorption (HP:0002630) | 3.59519323 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.55053711 |
| 12 | Meckel diverticulum (HP:0002245) | 3.35839494 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.33478557 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.29897974 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.27969409 |
| 16 | Hyperglycinemia (HP:0002154) | 3.20891202 |
| 17 | Acute encephalopathy (HP:0006846) | 3.20195960 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17978701 |
| 19 | Abnormality of the ileum (HP:0001549) | 3.16058889 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10250780 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.06944658 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 3.01589755 |
| 23 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.00671557 |
| 24 | Abnormal lung lobation (HP:0002101) | 2.96051399 |
| 25 | Type I diabetes mellitus (HP:0100651) | 2.87838354 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.87556517 |
| 27 | Reduced antithrombin III activity (HP:0001976) | 2.85592744 |
| 28 | Abnormality of the preputium (HP:0100587) | 2.81379218 |
| 29 | Onycholysis (HP:0001806) | 2.80924150 |
| 30 | Joint stiffness (HP:0001387) | 2.78024077 |
| 31 | Myositis (HP:0100614) | 2.74262468 |
| 32 | Abnormality of chromosome stability (HP:0003220) | 2.73768866 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 2.72764823 |
| 34 | Decreased subcutaneous fat (HP:0001002) | 2.70904165 |
| 35 | Exocrine pancreatic insufficiency (HP:0001738) | 2.69343171 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.67598545 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.67598545 |
| 38 | Cerebral edema (HP:0002181) | 2.67246091 |
| 39 | Degeneration of anterior horn cells (HP:0002398) | 2.67137013 |
| 40 | Abnormality of the anterior horn cell (HP:0006802) | 2.67137013 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66404702 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.66336368 |
| 43 | Orchitis (HP:0100796) | 2.59934808 |
| 44 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.59913962 |
| 45 | Duodenal stenosis (HP:0100867) | 2.58776890 |
| 46 | Small intestinal stenosis (HP:0012848) | 2.58776890 |
| 47 | Urticaria (HP:0001025) | 2.58368770 |
| 48 | Parakeratosis (HP:0001036) | 2.53726666 |
| 49 | Periodontitis (HP:0000704) | 2.53432834 |
| 50 | Pancreatitis (HP:0001733) | 2.52417873 |
| 51 | Increased CSF lactate (HP:0002490) | 2.50826020 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.50413090 |
| 53 | Cholecystitis (HP:0001082) | 2.50413090 |
| 54 | Increased hepatocellular lipid droplets (HP:0006565) | 2.50005689 |
| 55 | Beaking of vertebral bodies (HP:0004568) | 2.49704339 |
| 56 | Premature loss of primary teeth (HP:0006323) | 2.47251660 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.43999983 |
| 58 | Hypoplastic pelvis (HP:0008839) | 2.42515287 |
| 59 | Petechiae (HP:0000967) | 2.42335614 |
| 60 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.41169762 |
| 61 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.41169762 |
| 62 | Abnormal protein glycosylation (HP:0012346) | 2.41169762 |
| 63 | Abnormal glycosylation (HP:0012345) | 2.41169762 |
| 64 | Axonal loss (HP:0003447) | 2.40838911 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.40579052 |
| 66 | Optic neuritis (HP:0100653) | 2.40579052 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.40420585 |
| 68 | Type I transferrin isoform profile (HP:0003642) | 2.40037906 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.40002755 |
| 70 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.39854734 |
| 71 | Stomatitis (HP:0010280) | 2.38107417 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.35289026 |
| 73 | Plantar hyperkeratosis (HP:0007556) | 2.34731493 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.34418103 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34037346 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34037346 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34037346 |
| 78 | Abnormality of the labia minora (HP:0012880) | 2.33745672 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 2.29738346 |
| 80 | Premature skin wrinkling (HP:0100678) | 2.29161701 |
| 81 | Reticulocytopenia (HP:0001896) | 2.28106818 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.27884942 |
| 83 | Abnormality of the duodenum (HP:0002246) | 2.27478449 |
| 84 | Progressive macrocephaly (HP:0004481) | 2.27355826 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25026490 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25026490 |
| 87 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25026490 |
| 88 | Cortical dysplasia (HP:0002539) | 2.24871667 |
| 89 | Lipid accumulation in hepatocytes (HP:0006561) | 2.24828462 |
| 90 | Vascular calcification (HP:0004934) | 2.24277318 |
| 91 | Anhidrosis (HP:0000970) | 2.22085884 |
| 92 | Abnormality of the lumbar spine (HP:0100712) | 2.22041062 |
| 93 | Increased nuchal translucency (HP:0010880) | 2.22030564 |
| 94 | Hypoproteinemia (HP:0003075) | 2.21523084 |
| 95 | Erythema (HP:0010783) | 2.20379493 |
| 96 | Microglossia (HP:0000171) | 2.20212968 |
| 97 | Recurrent skin infections (HP:0001581) | 2.19509694 |
| 98 | Myocardial infarction (HP:0001658) | 2.18373988 |
| 99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.16898636 |
| 100 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15901674 |
| 101 | Abnormality of glycine metabolism (HP:0010895) | 2.15901674 |
| 102 | Progressive neurologic deterioration (HP:0002344) | 2.13629600 |
| 103 | Bifid tongue (HP:0010297) | 2.13287445 |
| 104 | Pustule (HP:0200039) | 2.12710259 |
| 105 | Prolonged partial thromboplastin time (HP:0003645) | 2.12678694 |
| 106 | Short chin (HP:0000331) | 2.12089342 |
| 107 | Hepatocellular necrosis (HP:0001404) | 2.11058283 |
| 108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.08905639 |
| 109 | Poor head control (HP:0002421) | 2.08625463 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.08484501 |
| 111 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.08239594 |
| 112 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.08239594 |
| 113 | Single umbilical artery (HP:0001195) | 2.08239594 |
| 114 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.07653268 |
| 115 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.06774223 |
| 116 | Hepatic necrosis (HP:0002605) | 2.05250816 |
| 117 | Gingivitis (HP:0000230) | 2.05193532 |
| 118 | Hypoplasia of the uterus (HP:0000013) | 2.05083853 |
| 119 | Cardiovascular calcification (HP:0011915) | 2.04882928 |
| 120 | Birth length less than 3rd percentile (HP:0003561) | 2.04150116 |
| 121 | Increased serum lactate (HP:0002151) | 2.04142236 |
| 122 | Colon cancer (HP:0003003) | 2.03488842 |
| 123 | Adrenal hypoplasia (HP:0000835) | 2.03224372 |
| 124 | Glomerulonephritis (HP:0000099) | 2.01772033 |
| 125 | Disinhibition (HP:0000734) | 2.01636974 |
| 126 | Deep venous thrombosis (HP:0002625) | 1.99669888 |
| 127 | Intrahepatic cholestasis (HP:0001406) | 1.99461376 |
| 128 | Palmoplantar hyperkeratosis (HP:0000972) | 1.99054838 |
| 129 | Short tibia (HP:0005736) | 1.98535052 |
| 130 | Facial cleft (HP:0002006) | 1.98130872 |
| 131 | Thick nail (HP:0001805) | 1.98103843 |
| 132 | Triphalangeal thumb (HP:0001199) | 1.97198746 |
| 133 | Maternal diabetes (HP:0009800) | 1.97024864 |
| 134 | Abnormality of the carotid arteries (HP:0005344) | 1.96414668 |
| 135 | Hypergammaglobulinemia (HP:0010702) | 1.94599570 |
| 136 | Popliteal pterygium (HP:0009756) | 1.93407212 |
| 137 | Vasculitis (HP:0002633) | 1.93033821 |
| 138 | Volvulus (HP:0002580) | 1.92648991 |
| 139 | Abnormality of the pons (HP:0007361) | 1.90563145 |
| 140 | Postnatal microcephaly (HP:0005484) | 1.90390448 |
| 141 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.90278880 |
| 142 | Dry hair (HP:0011359) | 1.90144630 |
| 143 | Sloping forehead (HP:0000340) | 1.89785257 |
| 144 | Absent radius (HP:0003974) | 1.88349725 |
| 145 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87704936 |
| 146 | Lactic acidosis (HP:0003128) | 1.86932877 |
| 147 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86806156 |
| 148 | Hypotrichosis (HP:0001006) | 1.86751180 |
| 149 | Supernumerary spleens (HP:0009799) | 1.86045603 |
| 150 | Abnormality of the umbilical cord (HP:0010881) | 1.85647407 |
| 151 | Abnormal tarsal ossification (HP:0008369) | 1.84235611 |
| 152 | Renal Fanconi syndrome (HP:0001994) | 1.84129090 |
| 153 | Hyperglycinuria (HP:0003108) | 1.83745417 |
| 154 | Hypoplasia of the pons (HP:0012110) | 1.81336188 |
| 155 | Microvesicular hepatic steatosis (HP:0001414) | 1.80975054 |
| 156 | Absent forearm bone (HP:0003953) | 1.80913427 |
| 157 | Aplasia involving forearm bones (HP:0009822) | 1.80913427 |
| 158 | Tetraparesis (HP:0002273) | 1.80729866 |
| 159 | Abnormal hemoglobin (HP:0011902) | 1.80182617 |
| 160 | Thrombocytosis (HP:0001894) | 1.79882173 |
| 161 | Palmar hyperkeratosis (HP:0010765) | 1.79341051 |
| 162 | Horseshoe kidney (HP:0000085) | 1.78746642 |
| 163 | Patchy hypopigmentation of hair (HP:0011365) | 1.76899327 |
| 164 | Right ventricular cardiomyopathy (HP:0011663) | 1.76439079 |
| 165 | Hypoplasia of the odontoid process (HP:0003311) | 1.76135718 |
| 166 | Basal ganglia calcification (HP:0002135) | 1.75235918 |
| 167 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.74569156 |
| 168 | Gangrene (HP:0100758) | 1.73889707 |
| 169 | Vertebral compression fractures (HP:0002953) | 1.73164680 |
| 170 | Abnormality of the common coagulation pathway (HP:0010990) | 1.73157842 |
| 171 | Obstructive lung disease (HP:0006536) | 1.72654710 |
| 172 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72654710 |
| 173 | Osteolytic defects of the hand bones (HP:0009699) | 1.72456130 |
| 174 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.72456130 |
| 175 | Proximal placement of thumb (HP:0009623) | 1.71107650 |
| 176 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.70294631 |
| 177 | Sparse eyelashes (HP:0000653) | 1.69572597 |
| 178 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.69464608 |
| 179 | Generalized aminoaciduria (HP:0002909) | 1.66911163 |
| 180 | Exercise intolerance (HP:0003546) | 1.66300149 |
| 181 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.66104212 |
| 182 | Retinal dysplasia (HP:0007973) | 1.65460239 |
| 183 | Embryonal renal neoplasm (HP:0011794) | 1.63511931 |
| 184 | Overlapping toe (HP:0001845) | 1.61385387 |
| 185 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.61195531 |
| 186 | Irregular epiphyses (HP:0010582) | 1.61063083 |
| 187 | Lethargy (HP:0001254) | 1.59322031 |
| 188 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.58808160 |
| 189 | Absent epiphyses (HP:0010577) | 1.58808160 |
| 190 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.58469060 |
| 191 | Preaxial hand polydactyly (HP:0001177) | 1.55899632 |
| 192 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.55726593 |
| 193 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.55726593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.50754198 |
| 2 | BUB1 | 4.47706533 |
| 3 | NEK1 | 3.51463635 |
| 4 | ERN1 | 3.49056826 |
| 5 | WEE1 | 3.18260401 |
| 6 | IRAK3 | 3.08094978 |
| 7 | CDC7 | 3.06765985 |
| 8 | NME2 | 2.94551461 |
| 9 | MAP3K14 | 2.83164060 |
| 10 | TTK | 2.66442899 |
| 11 | SRPK1 | 2.57651599 |
| 12 | PBK | 2.55628388 |
| 13 | TRIM28 | 2.54538865 |
| 14 | EIF2AK1 | 2.51942119 |
| 15 | IRAK4 | 2.51185466 |
| 16 | EIF2AK3 | 2.49762201 |
| 17 | PIM2 | 2.48539733 |
| 18 | PLK4 | 2.46619157 |
| 19 | VRK2 | 2.39767366 |
| 20 | TBK1 | 2.39181971 |
| 21 | MST4 | 2.27412555 |
| 22 | MAP2K2 | 2.13452875 |
| 23 | PLK3 | 2.09833185 |
| 24 | MST1R | 2.03504956 |
| 25 | MAP3K3 | 1.95845239 |
| 26 | MAPKAPK3 | 1.88404210 |
| 27 | BLK | 1.87629914 |
| 28 | STK16 | 1.83042877 |
| 29 | BRSK2 | 1.81241258 |
| 30 | ZAK | 1.78486797 |
| 31 | IKBKE | 1.74339373 |
| 32 | TSSK6 | 1.74062495 |
| 33 | PLK1 | 1.71952060 |
| 34 | FRK | 1.69510417 |
| 35 | MAP4K2 | 1.67423444 |
| 36 | BRSK1 | 1.65985517 |
| 37 | MKNK1 | 1.61173944 |
| 38 | TYK2 | 1.54940054 |
| 39 | RIPK4 | 1.52877358 |
| 40 | VRK1 | 1.50753710 |
| 41 | CCNB1 | 1.49287972 |
| 42 | IKBKB | 1.45439163 |
| 43 | IRAK2 | 1.44906417 |
| 44 | PIK3CG | 1.44327485 |
| 45 | MKNK2 | 1.39731266 |
| 46 | ZAP70 | 1.35262258 |
| 47 | IRAK1 | 1.33374800 |
| 48 | TGFBR2 | 1.31141659 |
| 49 | NEK2 | 1.30023697 |
| 50 | NEK9 | 1.29595926 |
| 51 | MAP3K12 | 1.27794676 |
| 52 | PLK2 | 1.26050127 |
| 53 | LIMK1 | 1.24964204 |
| 54 | AURKB | 1.22339145 |
| 55 | MAP3K2 | 1.18942731 |
| 56 | TRPM7 | 1.17267071 |
| 57 | CSNK1G3 | 1.15188504 |
| 58 | NUAK1 | 1.13333995 |
| 59 | KIT | 1.12055365 |
| 60 | WNK3 | 1.10978340 |
| 61 | EPHB1 | 1.10886448 |
| 62 | JAK3 | 1.10455934 |
| 63 | CHEK2 | 1.08589252 |
| 64 | BMPR1B | 1.07996094 |
| 65 | TAOK3 | 1.07207519 |
| 66 | MAPK15 | 1.06515151 |
| 67 | ATR | 1.05573195 |
| 68 | INSRR | 1.03869191 |
| 69 | TXK | 1.02248756 |
| 70 | CSNK1A1L | 1.01528219 |
| 71 | CSNK1G1 | 1.00959644 |
| 72 | CSNK1G2 | 0.99940037 |
| 73 | TEC | 0.95562747 |
| 74 | SCYL2 | 0.95527706 |
| 75 | CSK | 0.93961335 |
| 76 | MAP4K1 | 0.92709723 |
| 77 | CDK7 | 0.92567098 |
| 78 | ERBB3 | 0.90837193 |
| 79 | EPHB2 | 0.90782306 |
| 80 | ERBB4 | 0.89216448 |
| 81 | ARAF | 0.86601330 |
| 82 | BMPR2 | 0.85855597 |
| 83 | MINK1 | 0.85368839 |
| 84 | RPS6KB2 | 0.84872617 |
| 85 | TESK1 | 0.84462917 |
| 86 | AURKA | 0.84133210 |
| 87 | ADRBK2 | 0.83054475 |
| 88 | PAK4 | 0.82224396 |
| 89 | PNCK | 0.81631520 |
| 90 | LRRK2 | 0.81579981 |
| 91 | CASK | 0.81496416 |
| 92 | SIK3 | 0.80112157 |
| 93 | CHUK | 0.79612042 |
| 94 | DYRK2 | 0.79171922 |
| 95 | CDK8 | 0.78978828 |
| 96 | JAK1 | 0.78365115 |
| 97 | MET | 0.78364203 |
| 98 | TESK2 | 0.76126629 |
| 99 | EPHA2 | 0.74727740 |
| 100 | EPHA3 | 0.74481384 |
| 101 | BCR | 0.74068247 |
| 102 | BTK | 0.73108842 |
| 103 | MAP3K13 | 0.71879542 |
| 104 | BRAF | 0.71861612 |
| 105 | GRK7 | 0.71573186 |
| 106 | PIK3CA | 0.71056997 |
| 107 | FER | 0.70545152 |
| 108 | MAPKAPK5 | 0.70495304 |
| 109 | STK39 | 0.70273410 |
| 110 | RIPK1 | 0.69652703 |
| 111 | CDK18 | 0.69017522 |
| 112 | CDK14 | 0.67751763 |
| 113 | CHEK1 | 0.65145004 |
| 114 | STK38L | 0.64783812 |
| 115 | LYN | 0.64557913 |
| 116 | CSF1R | 0.63806586 |
| 117 | DYRK3 | 0.63418328 |
| 118 | TNIK | 0.63329263 |
| 119 | MAP2K1 | 0.63078428 |
| 120 | FLT3 | 0.62827497 |
| 121 | ABL1 | 0.62499106 |
| 122 | ATM | 0.62491427 |
| 123 | CDK15 | 0.59892798 |
| 124 | MATK | 0.59550890 |
| 125 | EIF2AK2 | 0.59338718 |
| 126 | DYRK1B | 0.58657087 |
| 127 | CSNK2A1 | 0.57748324 |
| 128 | STK3 | 0.57362666 |
| 129 | CDK11A | 0.56208439 |
| 130 | GRK1 | 0.55958864 |
| 131 | SYK | 0.55937119 |
| 132 | MAP3K8 | 0.55616300 |
| 133 | MAP2K6 | 0.54827281 |
| 134 | CAMKK2 | 0.53677113 |
| 135 | ABL2 | 0.53348636 |
| 136 | TAF1 | 0.53133536 |
| 137 | PRKG2 | 0.52926153 |
| 138 | MAPKAPK2 | 0.52252981 |
| 139 | LCK | 0.50857413 |
| 140 | MAP2K7 | 0.50473640 |
| 141 | PRKCD | 0.50442903 |
| 142 | KDR | 0.50192032 |
| 143 | YES1 | 0.50180071 |
| 144 | CSNK2A2 | 0.49743125 |
| 145 | PTK6 | 0.49395645 |
| 146 | FGFR1 | 0.48804419 |
| 147 | EPHA4 | 0.48469927 |
| 148 | SIK1 | 0.48313481 |
| 149 | LATS1 | 0.47977895 |
| 150 | RPS6KA4 | 0.47414884 |
| 151 | NLK | 0.46755429 |
| 152 | PDK2 | 0.44056194 |
| 153 | FGR | 0.43500175 |
| 154 | JAK2 | 0.43016728 |
| 155 | NEK6 | 0.41770508 |
| 156 | CDK1 | 0.41596178 |
| 157 | PRKCI | 0.41544280 |
| 158 | HCK | 0.41507136 |
| 159 | PAK2 | 0.40645012 |
| 160 | PIM1 | 0.40235850 |
| 161 | TLK1 | 0.39685617 |
| 162 | DAPK1 | 0.39517812 |
| 163 | PRKCE | 0.39412514 |
| 164 | STK10 | 0.38892542 |
| 165 | IGF1R | 0.38433382 |
| 166 | MAP2K3 | 0.38270309 |
| 167 | FGFR3 | 0.37694545 |
| 168 | LATS2 | 0.35827202 |
| 169 | TGFBR1 | 0.35559386 |
| 170 | STK4 | 0.35237993 |
| 171 | RPS6KA5 | 0.34158758 |
| 172 | PRKCG | 0.33527677 |
| 173 | MOS | 0.32750130 |
| 174 | ITK | 0.32568594 |
| 175 | ACVR1B | 0.32460153 |
| 176 | NME1 | 0.32416046 |
| 177 | CDK2 | 0.31378179 |
| 178 | MAP3K4 | 0.31055236 |
| 179 | CSNK1E | 0.30363631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 4.88567026 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.04076224 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.28980101 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.27458856 |
| 5 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.26910818 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.12987290 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 3.09437642 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28591203 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.26932768 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.21199469 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19931359 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13353221 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.13218488 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.07005359 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99382930 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.96444167 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.93734485 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.89772949 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82088443 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.81713369 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.81346954 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76879719 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.76865113 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.75743786 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75741180 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75565738 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.74294974 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.70885188 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.70139900 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.70123665 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.70119072 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.70062325 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.62171830 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62014461 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58861255 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.57363346 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 1.54784165 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.52629793 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.51851376 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.50819083 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.49973028 |
| 42 | Spliceosome_Homo sapiens_hsa03040 | 1.49701381 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.49424779 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49397539 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.49350355 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.48509371 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48458168 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.46746440 |
| 49 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.46582560 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45455356 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.44498066 |
| 52 | RNA transport_Homo sapiens_hsa03013 | 1.43286552 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.41297273 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40271666 |
| 55 | Malaria_Homo sapiens_hsa05144 | 1.39980084 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39649100 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.37129149 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36534429 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.35021634 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.29438621 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.28818032 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28169316 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28135598 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26008087 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25313314 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 1.23772106 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23015751 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20255468 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18338894 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17897140 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17386806 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17202356 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16347583 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15612918 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14121042 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09827123 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 1.09353374 |
| 78 | Asthma_Homo sapiens_hsa05310 | 1.04965409 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 1.04412836 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04064226 |
| 81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00684234 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.99409837 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98747593 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96127963 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.96098340 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93174383 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92967485 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92459490 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91844812 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91631703 |
| 91 | Ribosome_Homo sapiens_hsa03010 | 0.90383647 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89858126 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88789862 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88446655 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87030404 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86912651 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.84481411 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84428054 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84404980 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84287665 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82050326 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82001795 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81323805 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80850181 |
| 105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80611841 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78331282 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.78256022 |
| 108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78232768 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78179497 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77532875 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76156066 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75368810 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.74618546 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72282184 |
| 115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71855723 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71269557 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71154266 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71141194 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69027786 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69021664 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66488439 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.65904250 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.65550272 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64369324 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63268649 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61085338 |
| 127 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60834191 |
| 128 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59572802 |
| 129 | * Folate biosynthesis_Homo sapiens_hsa00790 | 0.58222898 |
| 130 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57350624 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56371250 |
| 132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56314692 |
| 133 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56050879 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54691300 |
| 135 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54170599 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.53069345 |
| 137 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53048455 |
| 138 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51118804 |
| 139 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50589607 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.47967621 |
| 141 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45054664 |
| 142 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44261846 |
| 143 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43977419 |
| 144 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43224653 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42523907 |
| 146 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41343947 |
| 147 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39900409 |
| 148 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39462493 |
| 149 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39440320 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39201685 |
| 151 | Shigellosis_Homo sapiens_hsa05131 | 0.38737138 |
| 152 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38362922 |
| 153 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36054600 |
| 154 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35004695 |
| 155 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34662815 |
| 156 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34485296 |
| 157 | Amoebiasis_Homo sapiens_hsa05146 | 0.32415813 |
| 158 | Lysine degradation_Homo sapiens_hsa00310 | 0.32379716 |
| 159 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31145961 |
| 160 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.29952466 |
| 161 | Hepatitis B_Homo sapiens_hsa05161 | 0.29527449 |
| 162 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28738747 |
| 163 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28628643 |
| 164 | Alcoholism_Homo sapiens_hsa05034 | 0.27050295 |
| 165 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.26820708 |
| 166 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.23537429 |
| 167 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22575009 |

